Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency (Neuronal Ceroid Lipofuscinosis Type 2) Patients

NCT04098211 is registered in ClinicalTrials.gov with Children's Hospital of Orange County as lead sponsor.

NCT NCT04098211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04098211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency (Neuronal Ceroid Lipofuscinosis Type 2) Patients
Lead sponsor
Children's Hospital of Orange County
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2019
Completion date
December 31, 2026
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuronal ceroid lipofuscinosis cln2, neuronal ceroid-lipofuscinoses, spinocerebellar ataxia, autosomal recessive 7